Pharming Group (OTCMKTS:PHGUF – Get Free Report)’s share price passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $0.81 and traded as high as $0.99. Pharming Group shares last traded at $0.98, with a volume of 3,000 shares trading hands.
Pharming Group Stock Performance
The stock has a market cap of $640.67 million, a price-to-earnings ratio of -49.10 and a beta of 1.11. The business has a 50-day simple moving average of $0.81 and a two-hundred day simple moving average of $0.81. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.76 and a current ratio of 3.53.
About Pharming Group
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome.
Read More
- Five stocks we like better than Pharming Group
- How to Invest in Biotech Stocks
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
- Energy and Oil Stocks Explained
- Top 3 ETFs to Hedge Against Inflation in 2025
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- These 3 Chip Stock Kings Are Still Buys for 2025
Receive News & Ratings for Pharming Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharming Group and related companies with MarketBeat.com's FREE daily email newsletter.